AJP - Regu AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 290: R202-R207, 2006. First published September 15, 2005; doi:10.1152/ajpregu.00502.2005
0363-6119/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/R202    most recent
00502.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gotoh, K.
Right arrow Articles by Woods, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gotoh, K.
Right arrow Articles by Woods, S. C.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Apolipoprotein A-IV interacts synergistically with melanocortins to reduce food intake

Koro Gotoh,1 Min Liu,2 Stephen C. Benoit,1 Deborah J. Clegg,1 W. Sean Davidson,2 David D'Alessio,3 Randy J. Seeley,1 Patrick Tso,2 and Stephen C. Woods1

Departments of 1Psychiatry, 2Pathology, and 3Medicine, University of Cincinnati, Cincinnati, Ohio

Submitted 11 July 2005 ; accepted in final form 25 August 2005

Apolipoprotein (apo) A-IV is an anorexigenic gastrointestinal peptide that is also synthesized in the hypothalamus. The goal of these experiments was to determine whether apo A-IV interacts with the central melanocortin (MC) system in the control of feeding. The third ventricular (i3vt) administration of a subthreshold dose of apo A-IV (0.5 µg) potentiated i3vt MC-induced (metallothionein-II, 0.03 nmol) suppression of 30-min feeding in Long-Evans rats. A subthreshold dose of the MC antagonist (SHU9119, 0.1 nmol, i3vt) completely attenuated the anorectic effect of i3vt apo A-IV (1.5 µg). The i3vt apo A-IV significantly elevated the expression of c-Fos in neurons of the paraventricular nucleus of the hypothalamus, but not in the arcuate nucleus or median eminence. In addition, c-Fos expression was not colocalized with proopiomelanocortin-positive neurons. These data support a synergistic interaction between apo A-IV and melanocortins that reduces food intake by acting downstream of the arcuate.

melanocortin system; hypothalamus; proopiomelanocortin; c-Fos


Address for reprint requests and other correspondence: S. C. Woods, Dept. of Psychiatry, Univ. of Cincinnati, 2170 East Galbraith Road, Cincinnati, OH 45237 (e-mail: steve.woods{at}psychiatry.uc.edu)




This article has been cited by other articles:


Home page
 DiabetesHome page
L. Shen, P. Tso, S. C. Woods, D. J. Clegg, K. L. Barber, K. Carey, and M. Liu
Brain Apolipoprotein E: an Important Regulator of Food Intake in Rats
Diabetes, August 1, 2008; 57(8): 2092 - 2098.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.